Unique Crypto Strategies
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Unique Crypto Strategies

Investing

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

by May 7, 2025
May 7, 2025
Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

Radiopharm Theranostics (ASX:RAD, Nasdaq: RADX, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that members of management will be participating in the D. Boral Capital Inaugural Global Conference on May 14, 2025, in New York City.

To register for one-on-one meetings with management in New York City, interested parties should contact John Perez at jperez@dboralcapital.com.

About Radiopharm Theranostics

Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm is listed on ASX (RAD) and on NASDAQ (RADX). The company has a pipeline of distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase 2 and three Phase 1 trials in a variety of solid tumor cancers including lung, breast, and brain. Learn more at radiopharmtheranostics.com .

Authorized on behalf of the Radiopharm Theranostics Board of Directors by Executive Chairman Paul Hopper.

For more information:

Investors:
Riccardo Canevari
CEO & Managing Director
P: +1 862 309 0293
E: rc@radiopharmtheranostics.com

Anne Marie Fields
Precision AQ (formerly Stern IR)
E: annemarie.fields@precisionaq.com

Media:
Matt Wright
NWR Communications
P: +61 451 896 420
E: matt@nwrcommunications.com.au

Follow Radiopharm Theranostics:
Website – https://radiopharmtheranostics.com/
X – https://x.com/TeamRadiopharm
LinkedIn – https://www.linkedin.com/company/radiopharm-theranostics/
InvestorHub – https://investorhub.radiopharmtheranostics.com/

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Durbin calls on DOJ to investigate anonymous pizza deliveries to judges’ homes
next post
Denarius Metals Announces Binding Letter of Intent with Quimbaya Gold for a 50/50 Joint Venture to Exploit the Tahami Project in the Segovia Gold District of Colombia

You may also like

Grande Portage Completes Non-Brokered Private Placement

Blackstone Merger to Acquire World Class Copper Gold...

What Factors Impact Graphene Cost?

Brunswick Exploration Discovers Greenland’s First Spodumene Pegmatite in...

Prismo Metals Appoints Gordon Aldcorn as President

Juggernaut Closes $1,100,000 from Institutions and Accredited Investors

As Part of Its New Development Strategy, Cartier...

RUA GOLD’s Drill Program Intersects near Surface Gold...

Cygnus Metals Limited: Cleansing Notice

Mount Hope Mining

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Hegseth tears up red tape, orders Pentagon to begin drone surge at...

    • SCOOP: Sen Ron Johnson readies subpoenas for FBI, DOJ in Butler shooting probe

    • Jackson defends controversial, fiery SCOTUS dissents as telling people ‘how I feel’

    • White House accuses Powell of mismanaging Federal Reserve, citing headquarters renovation

    • Italian chocolate giant Ferrero to buy Kellogg’s Froot Loops maker

    Categories

    • Business (544)
    • Investing (2,685)
    • Politics (4,282)
    • Uncategorized (1)
    • World (2,735)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: uniquecryptostrategies.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 uniquecryptostrategies.com | All Rights Reserved


    Back To Top